Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action

The use of pharmaceuticals for colon cancer treatment has been increasingly personalized, in part due to the development of new molecular tools. In this review, we discuss the old and new colon cancer chemotherapeutics, and the parameters that have been shown to be predictive of efficacy and safety...

Full description

Saved in:
Bibliographic Details
Main Authors: Wafik S. El-Deiry (Author), Christina Leah B. Kline (Author)
Format: Book
Published: MDPI AG, 2013-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f0851ab3ad534b6886ed1e752dc3ae78
042 |a dc 
100 1 0 |a Wafik S. El-Deiry  |e author 
700 1 0 |a Christina Leah B. Kline  |e author 
245 0 0 |a Personalizing Colon Cancer Therapeutics: Targeting Old and New Mechanisms of Action 
260 |b MDPI AG,   |c 2013-08-01T00:00:00Z. 
500 |a 10.3390/ph6080988 
500 |a 1424-8247 
520 |a The use of pharmaceuticals for colon cancer treatment has been increasingly personalized, in part due to the development of new molecular tools. In this review, we discuss the old and new colon cancer chemotherapeutics, and the parameters that have been shown to be predictive of efficacy and safety of these chemotherapeutics. In addition, we discuss how alternate pharmaceuticals have been developed in light of a potential lack of response or resistance to a particular chemotherapeutic. 
546 |a EN 
690 |a colorectal cancer 
690 |a personalized medicine 
690 |a genetic polymorphisms 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 6, Iss 8, Pp 988-1038 (2013) 
787 0 |n http://www.mdpi.com/1424-8247/6/8/988 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/f0851ab3ad534b6886ed1e752dc3ae78  |z Connect to this object online.